Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCH OTCMKTS:ECIA NASDAQ:ICU NASDAQ:NRXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$1.30+1.2%$1.44$1.06▼$3.99$27.87M2.2111,806 shs8,311 shsECIAEncision$0.35+8.8%$0.33$0.21▼$0.50$5.87M0.76,210 shs180 shsICUSeaStar Medical$0.90+2.4%$0.75$0.31▼$5.50$25.02M-13.06 million shs148,654 shsNRXSNeurAxis$2.44-0.4%$2.52$1.33▼$6.20$24.09M3.1614,747 shs2,176 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-2.29%-0.78%-16.34%-11.72%-60.62%ECIAEncision+8.75%+5.04%+16.00%-7.05%-4.63%ICUSeaStar Medical+4.59%-4.41%+12.72%-29.41%-83.42%NRXSNeurAxis+1.24%-6.84%-0.41%-1.61%-21.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$1.30+1.2%$1.44$1.06▼$3.99$27.87M2.2111,806 shs8,311 shsECIAEncision$0.35+8.8%$0.33$0.21▼$0.50$5.87M0.76,210 shs180 shsICUSeaStar Medical$0.90+2.4%$0.75$0.31▼$5.50$25.02M-13.06 million shs148,654 shsNRXSNeurAxis$2.44-0.4%$2.52$1.33▼$6.20$24.09M3.1614,747 shs2,176 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-2.29%-0.78%-16.34%-11.72%-60.62%ECIAEncision+8.75%+5.04%+16.00%-7.05%-4.63%ICUSeaStar Medical+4.59%-4.41%+12.72%-29.41%-83.42%NRXSNeurAxis+1.24%-6.84%-0.41%-1.61%-21.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 3.00Buy$9.25614.29% UpsideECIAEncision 0.00N/AN/AN/AICUSeaStar Medical 0.00N/AN/AN/ANRXSNeurAxis 3.00Buy$7.00186.89% UpsideCurrent Analyst Ratings BreakdownLatest ECIA, COCH, ICU, and NRXS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$7.00(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$222K125.54N/AN/A($0.88) per share-1.47ECIAEncision$6.55M0.90N/AN/A$0.14 per share2.49ICUSeaStar Medical$140K178.69N/AN/A($0.34) per share-2.64NRXSNeurAxis$3.22M7.49N/AN/A($0.27) per share-9.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$20.80M-$1.43N/AN/AN/A-10,961.26%N/A-236.14%11/13/2025 (Estimated)ECIAEncision-$220K-$0.02N/A∞N/A-4.34%-16.99%-7.45%11/12/2025 (Estimated)ICUSeaStar Medical-$24.83M-$2.62N/A∞N/A-1,915.27%N/A-232.65%11/11/2025 (Estimated)NRXSNeurAxis-$14.63M-$0.99N/A∞N/A-492.76%N/A-641.25%N/ALatest ECIA, COCH, ICU, and NRXS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025ICUSeaStar Medical-$0.43-$0.18+$0.25-$0.18$0.25 million$0.34 million7/31/2025Q2 2025COCHEnvoy Medical-$0.29-$0.32-$0.03-$0.32$0.07 million$0.08 million7/10/2025Q4 2025ECIAEncisionN/A-$0.01N/A-$0.01N/A$1.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A0.940.74ECIAEncision0.101.920.72ICUSeaStar MedicalN/A1.521.50NRXSNeurAxisN/A0.240.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%ECIAEncision8.20%ICUSeaStar Medical1.69%NRXSNeurAxis11.77%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical58.90%ECIAEncision36.75%ICUSeaStar Medical1.30%NRXSNeurAxis15.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3421.52 million8.85 millionNot OptionableECIAEncision3016.88 million10.68 millionNot OptionableICUSeaStar Medical227.92 million27.55 millionNot OptionableNRXSNeurAxis199.87 million6.09 millionNot OptionableECIA, COCH, ICU, and NRXS HeadlinesRecent News About These CompaniesNeurAxis Enters Market Offering Agreement with Craig-HallumSeptember 2, 2025 | tipranks.comNeurAxis Stock Down Following Q2 Earnings Despite Revenue GrowthAugust 18, 2025 | zacks.comNeurAxis, Inc. Reports Robust Q2 2025 GrowthAugust 13, 2025 | msn.comNeuraxis reports Q2 EPS (22c) vs. (42c) last yearAugust 12, 2025 | msn.comNeurAxis, Inc. (NRXS) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comEarnings Outlook For NeuraxisAugust 11, 2025 | benzinga.comNeuraxis ends Masimo license agreement and launches employee stock planJuly 5, 2025 | investing.comNeurAxis, Inc. (NASDAQ:NRXS) Major Shareholder Acquires $800,001.00 in StockJuly 4, 2025 | insidertrades.comNeurAxis, Inc. Ends Agreement with Masimo CorporationJuly 3, 2025 | tipranks.comNeurAxis, Inc. (NRXS) Latest Stock News & Headlines - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comThe Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxisJune 27, 2025 | sharewise.comSNeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal PainJune 17, 2025 | quiverquant.comQNeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered LivesJune 17, 2025 | globenewswire.comNeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBSJune 10, 2025 | finance.yahoo.comNeurAxis, Inc. Announces Inclusion of PENFS Technology in Pediatric Gastroenterology Guidelines for Functional Abdominal Pain TreatmentJune 10, 2025 | quiverquant.comQNeurAxis, Inc. Approves Key Proposals at Annual MeetingJune 4, 2025 | tipranks.comNeurAxis, Inc. Completes $5 Million Registered Direct Offering to Support Growth of IB-Stim TherapyMay 22, 2025 | quiverquant.comQNeurAxis Announces Closing of $5.0 Million Registered Direct OfferingMay 22, 2025 | globenewswire.comNeurAxis, Inc. Announces $5 Million Stock OfferingMay 22, 2025 | tipranks.comNeurAxis, Inc. Receives $1 Million from Warrant ExercisesMay 21, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025Super Micro Computer Stock Hasn't Priced in Growth YetBy Gabriel Osorio-Mazilli | August 25, 2025Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity By Gabriel Osorio-Mazilli | August 13, 20253 Undervalued Stocks Poised to Shine in the Next Market RallyBy Gabriel Osorio-Mazilli | September 8, 2025ECIA, COCH, ICU, and NRXS Company DescriptionsEnvoy Medical NASDAQ:COCH$1.30 +0.02 (+1.17%) As of 10:01 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Encision OTCMKTS:ECIA$0.35 +0.03 (+8.75%) As of 09/9/2025 03:55 PM EasternEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.SeaStar Medical NASDAQ:ICU$0.90 +0.02 (+2.36%) As of 10:02 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.NeurAxis NASDAQ:NRXS$2.44 -0.01 (-0.41%) As of 09:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing The Quiet Before the Catalyst: Vertical Aerospace's Next Move Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver Insiders Sell These High-Quality Stocks: Why Investors Shouldn’t Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
